within Pharmacolibrary.Drugs.ATC.P;

model P02BX01
  extends Pharmacokinetic.Models.PK_1C_enteral(
    weight         = 70,
    F              = 0.6,
    Cl             = 0.02,
    adminDuration  = 600,
    adminMass      = 0.5,
    adminCount     = 1,
    Vd             = 0.04,
    Cmin           = 0.001,
    Cmax           = 0.01,
    Ctox_peak      = 0.02,
    Ctox_trough    = 0.01,
    ka             = 0.0008333333333333334,
    Tlag           = 600
  );

  annotation(Documentation(
    info ="<html><body><p>Bithionol is a synthetic organochlorine compound formerly used as an anthelmintic and an alternative to niclosamide for the treatment of fascioliasis and paragonimiasis (liver and lung flukes) in humans and animals. Its use in humans has been discontinued or severely limited due to adverse effects.</p><h4>Pharmacokinetics</h4><p>Estimated typical adult PK parameters for oral administration based on historical reports and physicochemical characteristics. No clinically validated PK studies in human subjects published.</p><h4>References</h4><ol><li><p>Mourot, D, et al., &amp; Delepine, B (1987). Liquid chromatographic determination of depletion of bithionol sulfoxide and its two major metabolites in bovine milk. <i>Journal - Association of Official Analytical Chemists</i> 70(5) 810–812. PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/3680115/&quot;>https://pubmed.ncbi.nlm.nih.gov/3680115</a></p></li><li><p>Dagorn, M (1982). [Autoradiographic study of the distribution of 14C bithionol sulfoxide in mice (author&#x27;s transl)]. <i>Toxicological European research. Recherche europeenne en toxicologie</i> 4(2) 101–105. PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/7112565/&quot;>https://pubmed.ncbi.nlm.nih.gov/7112565</a></p></li></ol></body></html>",
    revisions = "<html><body><ul><li>06/2025 model generated by LLM gpt-4.1, references by scholarly and scripts created by Tomas Kulhanek</li></ul></body></html>"
  ));
end P02BX01;
